Modi Ventures
Venture capitalHouston · Seed–Series A · 20 people tracked
Investment thesis
Modi Ventures focuses on the convergence of technology and biology, investing early in platforms it calls the emerging 'bioeconomy.' The firm believes advances in genome sequencing and the combination of artificial intelligence with biology are transforming pharmaceuticals, therapeutics, diagnostics and prognostics, with broad implications for manufacturing, climate, agriculture, space and human health. It targets technology platforms that positively impact health, with particular emphasis on opportunities leveraging AI, microfluidics hardware, multiomics, precision medicine, synthetic biology, gene editing and living therapies. Modi invests in both funds and founders.
Source: firm website, verified Aug 3, 2026.
Team · 20 people
from the firm's website & public directories
What they invest in
from 28 of 54 portfolio companiesBiotech ×18Deep Tech ×11AI & Machine Learning ×10Healthtech ×9Medical Devices ×9Digital Health ×7Cloud Computing ×2Longevity ×2
HQs:United States×11United Kingdom×3New Zealand×1
Investments · 54 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 22020 · 14 dated
Abingworth is a life-sciences investment firm that backs early-stage biopharma and biotech companies, providing capital and operational support to help them develop new therapeutics.
BiotechLondon, GB
Brainomix, a spin-out from the University of Oxford, develops AI-powered imaging biomarkers and software that help physicians interpret medical images to support clinical decisions.
AI & Machine LearningDigital HealthMedical DevicesOxford, GB
Michalis Papadakis(CEO)Alastair Buchan(Co-founder; Oxford Professor of Stroke Medicine)
Cancer Focus Fund is an oncology-focused investment fund, established with The University of Texas MD Anderson Cancer Center, that finances early clinical-stage cancer therapies such as immunotherapies, cell therapies, precision medicine and radiotherapeutics.
BiotechHealthtech
Developing next-generation γδ T cell engagers as cancer therapies.
Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers.
BiotechHealthtech
Draper is a venture capital firm that invests in startups across AI and robotics, Bitcoin and blockchain, precision medicine and longevity, aerospace and space infrastructure, and frontier deeptech.
AI & Machine LearningCrypto & Web3Deep Tech
Early develops a home urinalysis system that pairs a clinical-grade electrochemical reader with disposable urine tests to screen for markers of serious conditions such as urinary tract cancers, diabetes, kidney disease, and heart disease risk, plus wellness markers, delivering results to an app in under five minutes.
Digital HealthHealthtechMedical Devices
Mark Emberton(Chief Medical Officer)
Evidence-based longevity intelligence platform for healthcare systems.
Developing therapy for neuropsychiatric symptoms of dementia, including agitation/aggression in Alzheimer's.
General Proximity develops proximity-based technologies for drug discovery and development.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Armand Cognetta(Founder)in
Developing next-generation protein sequencing platform to redefine proteomics.
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Joshua Yang(Founder & CEO)Daniel Estandian(Founder)Ed Boyden(Founder)Jimmy Yun(Director)
BoardCraig Asher(Director)
Groq designs and manufactures the LPU (Language Processing Unit), a chip purpose-built for AI inference, and operates GroqCloud, a platform for running inference workloads with low latency and cost efficiency across global data centers.
AI & Machine LearningCloud ComputingSemiconductors
Jonathan Ross(Founder & CEO)in
HealthTech Arkansas (HTA) helps medtech and healthtech companies from around the world enter the U.S. healthcare market by guiding U.S. strategy, arranging guaranteed hospital pilot projects and clinical trials through its coalition of clinical partners, and connecting them with U.S. investors.
Digital HealthHealthtechMedical Devices
Kamau Therapeutics develops targeted gene integration therapies to treat serious and life-threatening genetic diseases.
BiotechDeep TechHealthtechAustin, US
Matthew Porteus(Executive Officer, Director)Valentin Barsan(Executive Officer, Director)
BoardRaymond Kelleher(Director)Ness Bermingham(Director)
KOMO Biosciences develops genome engineering technology based on hyperactive large serine integrases to transform cell-based manufacturing of biologics and advanced therapies.
BiotechDeep Tech
Jennifer Manning(Founder & CEO)Thomas Page(Acting CTO)Matt Farabaugh(Acting CFO)Jesse B. Owens(Acting CSA)Ray Tabibiazar(Chairman of the Board)
LILA Sciences builds AI systems for autonomous scientific research and discovery across medicine, materials, energy, and defense sectors.
AI & Machine LearningBiotechDeep TechSaaS
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.
BiotechMedical DevicesHouston, US
Sarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)
BoardThomas Luby(Director)inPeter Olagunju(Director)inJoseph Petrosino(Director)
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
BiotechDeep TechMedical DevicesSeattle, US
Marc Lajoie(Co-founder & Chief Executive Officer)Scott Boyken(Co-founder & Chief Technology Officer)Stanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)Charity Scripture(Executive Officer)Eric Soller(Executive Officer)
PathPresenter is a digital pathology platform used for viewing, sharing, and managing pathology images in clinical, research, and educational settings.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Raj Singh(Founder)Rajendra Singh(Co-founder)Cory Batenchuk(Senior Vice President, Operations & Co-founder)KV Acharya(System Architect & Co-founder)Patrick Myles(Chief Executive Officer)
ProFound Therapeutics identifies previously undiscovered proteins encoded by the human genome and characterizes their biological functions to find new drug targets and therapeutic proteins.
BiotechDeep Tech
Discovers and develops medicines targeting pathologic cells that drive aging.
Rubedo Life Sciences develops therapeutics targeting aging by eliminating senescent cells to extend human healthspan.
AI & Machine LearningBiotechLongevityMedical Devices
Samsara Capital is an investment firm that backs the development of therapeutics for patients.
Biotech
Serif Biomedicines develops technology to write DNA in different forms so that DNA can be used as a medicine, aiming to create a new category of genetic medicines to treat and prevent disease.
BiotechDeep Tech
Diagnostics, labs, and digital health platform for accessible detection and care at enterprise scale.
T.Rx Capital is a venture capital firm that invests in and helps build early-stage biotech, healthcare, and medical technology companies, focusing on drug discovery, advanced therapeutic modalities, medical devices, diagnostics, and healthcare software.
BiotechDigital HealthMedical Devices
Kwesi Frimpong-Boateng(Co-founder & Managing Partner)Michael Langer(Co-founder & Managing Partner)Corey M. McCann(Co-founder & Managing Partner)Robert Langer(Executive Chairman & Chair of Scientific Advisory Board)
Combines in-person clinic and online care for pet health.
Tandem is a veterinary clinic providing wellness exams, vaccines, preventive care, urgent care, and specialty services for cats and dogs, operating a full-service clinic in Somerville plus mobile and telehealth services.
ConsumerHealthtechSomerville, US
Techion develops FECPAK, a portable digital microscope and data platform that provides digital diagnosis and data management for animal, human, and environmental health, serving farmers and animal health specialists.
AgTechAI & Machine LearningData & InfrastructureDigital HealthMedical Devices
Greg Mirams(Founder and Managing Director)
Tiny Health provides microbiome testing kits and personalized health reports for families from pregnancy through adulthood, focusing on gut health optimization to address conditions like eczema, allergies, IBS, and constipation.
Digital HealthHealthtechWellness & Fitness
Yosemite is working toward making cancer non-lethal, focusing on cancer research and treatment.
BiotechLongevitySan Francisco, US
Portfolio news
latest coverage across their companiesTiny Health · zeebiz.com · Jul 16, 2026
Lila Sciences · finsmes.com · Jun 4, 2026
General Proximity · pulse2.com · May 5, 2026
Rubedo Life Sciences · fightaging.org · Apr 8, 2026
Frequently asked questions
- What stage does Modi Ventures invest at?
- Modi Ventures invests at the Seed, Series A stages.
- What sectors does Modi Ventures focus on?
- Modi Ventures focuses on AgTech, AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Hardware, Healthtech, Longevity, Medical Devices, Space Tech.
- Where is Modi Ventures located?
- Modi Ventures is headquartered in Houston, US.
Media · Podcasts & interviews
featuring the teamRaising a 32 million venture fund in 30 days - Sahir Ali (Modi Ventures)
Learning with Rishad · Sahir Ali
Images
Co-investors · 1
Parkwalk Advisors is a UK-based investment manager focused on backing deeptech companies spun out of UK universities, bridging the gap between academic research and commercial success. It operates as part of IP Group plc and is a leading EIS fund manager.
Firms observed investing alongside Modi Ventures, from public investor directories. Shared companies are the overlap with Modi Ventures's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
Unruly Capital is a venture firm that backs founders working on ideas that seem too early or unconventional but are expected to become mainstream within a decade, focusing on frontier technology themes.
Future Positive Capital's portfolio page showcasing companies across health, climate, and deeptech sectors.
Snatched Ventures is a venture capital firm that partners with entrepreneurs pursuing bold, transformative visions, offering strategic support to help scale breakthrough innovations.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.